regulatory
confidence high
sentiment negative
materiality 0.75
AIM ImmunoTech Inc. (AIM): Nasdaq/NYSE listing notice — AIM ImmunoTech receives NYSE American delisting notice for low stock price; plans appeal
AIM ImmunoTech Inc.
- Received notice on April 4, 2025 from NYSE American of suspension and delisting under Section 1003(f)(v) due to low selling price.
- Company will appeal the delisting determination to the Listing Qualifications Panel; no guarantee of success.
- Common stock expected to begin trading on the Pink Open Market on April 7, 2025.
- Trading on NYSE American has been suspended effective April 4, 2025.